Filing Details

Accession Number:
0001209191-19-060072
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-12-11 17:21:22
Reporting Period:
2019-12-09
Accepted Time:
2019-12-11 17:21:22
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1503802 Karyopharm Therapeutics Inc. KPTI Pharmaceutical Preparations (2834) 263931704
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1588438 Sharon Shacham C/O Karyopharm Therapeutics Inc.
85 Wells Avenue
Newton MA 02459
President & Cso No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-12-09 10,000 $4.75 741,134 No 4 M Direct
Common Stock Disposition 2019-12-09 10,000 $17.02 731,134 No 4 S Direct
Common Stock Acquisiton 2019-12-10 10,000 $4.75 539,767 No 4 M Indirect By Spouse
Common Stock Disposition 2019-12-10 10,000 $15.99 529,767 No 4 S Indirect By Spouse
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Indirect By Spouse
No 4 S Indirect By Spouse
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2019-12-09 10,000 $0.00 10,000 $4.75
Common Stock Stock Option (right to buy) Disposition 2019-12-10 10,000 $0.00 10,000 $4.75
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
440,303 2023-09-02 No 4 M Direct
396,061 2023-09-02 No 4 M Indirect
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 29,685 Indirect By GRAT
Common Stock 29,685 Indirect By Spouse's GRAT
Footnotes
  1. These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
  2. Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $16.75 to $17.58, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
  3. These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the spouse of the reporting person.
  4. Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $15.61 to $16.45, inclusive. The spouse of the reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
  5. These shares are held by the Sharon Shacham 2016 Qualified Annuity Interest Trust.
  6. These shares are held by the Michael G. Kauffman 2016 Qualified Annuity Interest Trust.
  7. This option, representing a right to purchase a specified number of shares, vested as to 25% of the shares on September 3, 2014, and the remaining 75% vested in 36 equal monthly installments thereafter.